Please wait while we open this resource.
K
Clinical reviews
PRIMER CROHN’S DISEASE
Giulia Roda, Siew Chien Ng, Paulo Gustavo Kotze, Marjorie Argollo, Remo Panaccione, Antonino Spinelli, Arthur Kaser, Laurent Peyrin-Biroulet, Silvio Danese
PDF202019 pages2.1 MB
Crohn's disease is increasingly prevalent worldwide and is associated with various factors including immune dysregulation and genetic susceptibility. The document emphasizes the importance of early and personalized treatment to manage the disease effectively and prevent complications. It also highlights the need for ongoing research into biomarkers and severity scores to improve disease management and monitoring.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
ACUTE PANCREATITIS: MECHANISMS AND THERAPEUTIC APPROACHES
Same clinical topic · Gastroenterology
Functional Dyspepsia
Same clinical topic · Gastroenterology
AGA CLINICAL PRACTICE UPDATE ON EVALUATION AND MANAGEMENT OF REFRACTORY CONSTIPATION: EXPERT REVIEW
Same clinical topic · Gastroenterology
AGA CLINICAL PRACTICE UPDATE ON MANAGEMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION IN ADULTS: EXPERT REVIEW
Same clinical topic · Gastroenterology
CURRENT APPROACH TO DIAGNOSIS AND MANAGEMENT OF LOW-PHOSPHOLIPID ASSOCIATED CHOLELITHIASIS SYNDROME
Same clinical topic · Gastroenterology
PRIMER Ulcerative colitis
Same clinical topic · Gastroenterology
UNCOMPLICATED CHOLEDOCHOLITHIASIS IN ELDERLY PATIENTS: A TARGET TRIAL EMULATION COMPARING OBSERVATION AND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
Same clinical topic · Gastroenterology
CELIAC DISEASE
Same clinical topic · Gastroenterology
LINERIXIBAT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND CHOLESTATIC PRURITUS (GLISTEN): A RANDOMISED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIAL
Same clinical topic · Gastroenterology